Applied Cytometry Sponsors the Human Pluripotent Stem Cells Symposium
News Apr 17, 2009
Applied Cytometry will attend the Human Pluripotent Stem Cells symposium, the first ever major stem cell event to be held in Ireland. The three day event, held at the Croke Park Conference Centre in Dublin from 22nd – 24th April, will discuss both basic and therapeutic applications of human pluripotent stem cells and their differentiated derivatives and brings together an impressive list of international speakers in this focused and rapidly expanding area of medical science.
The event covers a number of key topics around pluripotent stem cells, to include epigenetic and reprogramming mechanisms underpinning derivation, maintenance and differentiation of human pluripotent stem cells. The emergence of human pluripotent stem cells as a platform for generating large quantities of disease-specific material will also be discussed, focusing specifically on two applications: disease modeling and drug screening.
Flow cytometry represents a powerful tool in stem cell research allowing simultaneous sorting of numerous parameters including multiple markers, generating greater amounts of data than ever before and so demanding increasingly capable analysis software.
Applied Cytometry recently launched its latest version of its VenturiOne® v3 flow cytometry data analysis software, specifically designed to handle vast amounts of data generated in for example stem cell research. The Company claims that the software can analyze up to 400 files concurrently in less than ten seconds and in addition to batch analysis, VenturiOne v3 also produces significantly enhanced reports, generated from within the software itself. Furthermore, its inherent flexibility and simplicity of set-up means VenturiOne manages the vast majority of a laboratory’s routine workload.
Commenting on this event, Dr Tracey Long, Marketing Manager at Applied Cytometry, said: “We are delighted to be attending the Human Pluripotent Stem Cells symposium this year. As flow cytometers continue to push boundaries in terms of their capabilities, software that can analyze vast amounts of data is essential. Stem cell research is one of the areas truly able to benefit from these increased technological advances and VenturiOne® v3 revolutionizes the analysis”.
Scleroderma Study Offers New Hope For SufferersNews
An unusual autoimmune disease that causes skin and lung damage can be treated effectively by stem cell transplant, a new study found. The approach could represent the first new treatment to improve survival in patients with severe scleroderma in more than four decades.READ MORE
Heart-muscle Patches Created from Human Cells Improve Recovery from Heart AttacksNews
Large, human cardiac-muscle patches created in the lab have been tested, for the first time, on large animals in a heart attack model. This clinically relevant approach showed that the patches significantly improved recovery from heart attack injury.READ MORE